Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and ...

Annovis is at the forefront, testing buntanetap in pivotal clinical trials as a therapy for Alzheimer's and Parkinson's diseases (PD). Company has filed three new patents protecting combinations of ...

From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...

US pharmaceutical giant Pfizer is poised to axe up to 200 jobs across its Irish operation. The proposed job losses – a total ...

KIRKLAND, QC, Sept. 19, 2024 /CNW/ - Today, Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV ...

Pfizer Inc has inaugurated its first commercial analytics centre in Mumbai, India. This global capability centre will serve Pfizer's international markets outside the US, employing data analytics ...

Some Pfizer investors are hungry for an encore and showing their displeasure by shunning the stock. The attitude has left the shares undervalued, in the opinion of one pundit (and his bullish view ...